LIVE

€3.11 ▲−7.10%

/Power Keepers/Medicham

Variants

HIGH · Conviction 6/10

Medicham

Power Keepers · #34 · Uncommon

Reference NM

€6.12

External reference · raw NM

PSA 9

€21.87

USD source

PSA 10

€85.74

USD source

Composite

5.9

Confidence 6/10

5.9

Live raw NM price unavailable from primary source — showing external reference.

View listing →View price reference →

Buy range€5.19 – €6.78Good buy

All prices and projections are for Near Mint English-language cards. Other conditions and languages may vary significantly.

Price history

Ungraded NM PSA 9 PSA 10

Investment thesis

Sub-score breakdown · ROI projections

5.9

SCORE / 10

Liquidity

8.6

Scarcity

10.0

Era potential

8.9

Friction

5.5

Hold-Raw · 5Y Outlook▲ PRIMARY

+•••%

Available with Pro

Grade or sell · per-card

Free account

See if grading this card pays.

How is this scored?

The composite score (0–10) blends signals across trust, set tier, era, liquidity, and price. The four sub-scores shown above (Liquidity, Scarcity, Era CAGR, Friction) describe each card across complementary axes; they share inputs with the composite but use different formulas. The Friction sub-score (added 2026-05-11) combines liquidity, price-spread stability, era maturity, and affordability minus a flat marketplace-fee proxy. The era-benchmark ROI numbers project returns based on the card's release era — they're not card-specific predictions. Limitations: the score is a relative ranking heuristic, not a forecast. Prices are snapshots and can drift between refreshes — always verify externally before buying.

Pop report

PSA 10 gem rate 6.85%Total population

PSA 10

PSA 9

PSA 8

Total graded

Gem rate 6.85%. Consistent with modern era gem rates; expect supply to grow as more are graded.

OVERVIEW

Investment summary

Medicham from the Power Keepers set (#34) currently trades at €6.12 in the raw market. Over the past 30 days the card has declined -23.3%. By market value it ranks #97 of 108 in Power Keepers — the 10th percentile of the set. With recent sales tracked over the trailing 180 days, liquidity is rated medium. Read together, a lower-tier ranking in Power Keepers alongside softening 30-day momentum frames where Medicham sits in the set's pricing structure — context worth weighing against the set's stronger names before timing an entry. Market data is informational only and does not constitute investment advice.